Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
September-2021 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 15 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Promoter polymorphism of TNF‑α (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population

  • Authors:
    • Kornyok Kamdee
    • Nitirat Panadsako
    • Onchuma Mueangson
    • Manit Nuinoon
    • Penchom Janwan
    • Wasinee Poonsawat
    • Pongphan Pongpanitanont
    • Nakarin Kitkumthorn
    • Jirapan Thongsroy
    • Warangkana Chunglok
  • View Affiliations / Copyright

    Affiliations: School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand, Research Institute for Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand, Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand, School of Medicine, Walailak University, Nakhon Si Thammarat 80160, Thailand
    Copyright: © Kamdee et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 78
    |
    Published online on: July 23, 2021
       https://doi.org/10.3892/br.2021.1454
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Stroke represents the leading cause of disability and mortality amongst the elderly worldwide. Multiple risk factors, including both genetic and non‑genetic components, as well as their interactions, are proposed as etiological factors involved in the development of ischemic stroke (IS). Promoter polymorphisms of the IL‑6‑174G/C (rs1800795) and TNF‑α‑308G/A (rs1800629) genes have been considered as predictive risk factors of IS; however, these have not yet been evaluated in a Thai population. The aims of this study were to investigate the association of IL‑6‑174G/C and TNF‑α‑308G/A polymorphisms with IS. Genomic DNA from 200 patients with IS and 200 controls were genotyped for IL‑6‑174G/C and TNF‑α‑308G/A polymorphisms using TaqMan™ SNP genotyping and quantitative PCR‑high resolution melting analysis, respectively. It was found that the TNF‑α‑308 A allele was significantly associated with an increased risk of IS development compared with the G allele [odds ratio (OR)=2.044; 95% CI=1.154‑3.620; P=0.014]. Moreover, the IS risk was significantly higher in the presence of TNF‑α‑308 GA or AA genotypes compared with that in the presence of GG genotypes with a dominant inheritance (OR=1.971; 95% CI=1.080‑3.599; P=0.027). However, there was no association between IL‑6‑174G/C and the risk of IS development. The interaction study demonstrated that IL‑6‑174 GG and TNF‑α‑308 GG genotypes enhanced IS susceptibility when combined with hypertension, hyperlipidemia and alcohol consumption. Hypertensive and hyperlipidemic subjects with the TNF‑α‑308 GA and AA genotypes were more likely to develop IS compared with those who did not have these two conditions and had the GG genotype. In a matched study design (1:1), the IL‑6‑174 GC genotype was associated with higher IL‑6 levels in the control group. Collectively, the present results highlight the utility of the TNF‑α‑308G/A polymorphism as a predictive genetic risk factor for development of IS.
View Figures

Figure 1

Figure 2

View References

1 

Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell PM, Feigin V, Norrving B, Owolabi M, Pandian J, et al: Global stroke statistics 2019. Int J Stroke. 15:819–838. 2020.PubMed/NCBI View Article : Google Scholar

2 

Boot E, Ekker MS, Putaala J, Kittner S, De Leeuw FE and Tuladhar AM: Ischaemic stroke in young adults: A global perspective. J Neurol Neurosurg Psychiatry. 91:411–417. 2020.PubMed/NCBI View Article : Google Scholar

3 

Avan A, Digaleh H, Di Napoli M, Stranges S, Behrouz R, Shojaeianbabaei G, Amiri A, Tabrizi R, Mokhber N, Spence JD and Azarpazhooh MR: Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: An ecological analysis from the Global Burden of Disease Study 2017. BMC Med. 17(191)2019.PubMed/NCBI View Article : Google Scholar

4 

The Thai Ministry of Public Health: Public Health Statistics A.D. 2019, 2020. Available from: https://bps.moph.go.th/new_bps/sites/default/files/statistic62.pdf.

5 

Yamada Y, Kato K, Oguri M, Horibe H, Fujimaki T, Yasukochi Y, Takeuchi I and Sakuma J: Identification of nine genes as novel susceptibility loci for early-onset ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage. Biomed Rep. 9:8–20. 2018.PubMed/NCBI View Article : Google Scholar

6 

Lee J, Park A, Mun S, Kim HJ, Son H, Choi H, Kim D, Lee SJ, Kim JG and Kang HG: Proteomics-based identification of diagnostic biomarkers related to risk factors and pathogenesis of ischemic stroke. Diagnostics (Basel). 10(340)2020.PubMed/NCBI View Article : Google Scholar

7 

Genchi A, Semerano A, Gullotta GS, Strambo D, Schwarz G, Bergamaschi A, Panni P, Simionato F, Scomazzoni F, Michelozzi C, et al: Cerebral thrombi of cardioembolic etiology have an increased content of neutrophil extracellular traps. J Neurol Sci. 423(117355)2021.PubMed/NCBI View Article : Google Scholar

8 

Clausen BH, Wirenfeldt M, Høgedal SS, Frich LH, Nielsen HH, Schrøder HD, Østergaard K, Finsen B, Kristensen BW and Lambertsen KL: Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke. Acta Neuropathol Commun. 8(81)2020.PubMed/NCBI View Article : Google Scholar

9 

Mo Y, Sun YY and Liu KY: Autophagy and inflammation in ischemic stroke. Neural Regen Res. 15:1388–1396. 2020.PubMed/NCBI View Article : Google Scholar

10 

Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM and Donnan GA: Ischaemic stroke. Nat Rev Dis Primers. 5(70)2019.PubMed/NCBI View Article : Google Scholar

11 

Meng H, Zhao H, Cao X, Hao J, Zhang H, Liu Y, Zhu MS, Fan L, Weng L, Qian L, et al: Double-negative T cells remarkably promote neuroinflammation after ischemic stroke. Proc Natl Acad Sci USA. 116:5558–5563. 2019.PubMed/NCBI View Article : Google Scholar

12 

Martha SR, Cheng Q, Fraser JF, Gong L, Collier LA, Davis SM, Lukins D, Alhajeri A, Grupke S and Pennypacker KR: Expression of cytokines and chemokines as predictors of stroke outcomes in acute ischemic stroke. Front Neurol. 10(1391)2020.PubMed/NCBI View Article : Google Scholar

13 

Zheng PF, Liao FJ, Yin RX, Chen LZ, Li H, Nie RJ, Wang Y and Liao PJ: Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke. Lipids Health Dis. 19(37)2020.PubMed/NCBI View Article : Google Scholar

14 

Chen M and Yang Y: A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke. J Neuroimmunol. 335(577004)2019.PubMed/NCBI View Article : Google Scholar

15 

Cui G, Wang H, Li R, Zhang L, Li Z, Wang Y, Hui R, Ding H and Wang DW: Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 9(235)2012.PubMed/NCBI View Article : Google Scholar

16 

Chakraborty B, Chowdhury D, Vishnoi G, Goswami B, Kishore J and Agarwal S: Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India. J Stroke Cerebrovasc Dis. 22:683–689. 2013.PubMed/NCBI View Article : Google Scholar

17 

Fabris M, Quartuccio L, Fabro C, Sacco S, Lombardi S, Ramonda R, Biasi D, Punzi D, Adami S, Olivieri I, et al: The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis. Pharmacogenomics J. 16:238–242. 2016.PubMed/NCBI View Article : Google Scholar

18 

Bank S, Julsgaard M, Abed OK, Burisch J, Broder Brodersen J, Pedersen NK, Gouliaev A, Ajan R, Nytoft Rasmussen D, Honore Grauslund C, et al: Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease. Aliment Pharmacol Ther. 49:890–903. 2019.PubMed/NCBI View Article : Google Scholar

19 

Rincon M: Interleukin-6: From an inflammatory marker to a target for inflammatory diseases. Trends Immunol. 33:571–577. 2012.PubMed/NCBI View Article : Google Scholar

20 

Klimiec-Moskal E, Piechota M, Pera J, Weglarczyk K, Slowik A, Siedlar M and Dziedzic T: The specific ex vivo released cytokine profile is associated with ischemic stroke outcome and improves its prediction. J Neuroinflammation. 17(7)2020.PubMed/NCBI View Article : Google Scholar

21 

Reiche EMV, Gelinksi JR, Alfieri DF, Flauzino T, Lehmann MF, de Araújo MCM, Lozovoy MAB, Simão ANC, de Almeida ERD and Maes M: Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death. Metab Brain Dis. 34:789–804. 2019.PubMed/NCBI View Article : Google Scholar

22 

Choi DW, Kim TS, Kim YS and Kim DJ: Elevated plasma biomarkers of inflammation in acute ischemic stroke patients with underlying dementia. BMC Neurol. 20(293)2020.PubMed/NCBI View Article : Google Scholar

23 

Kim JW, Park MS, Kim JT, Kang HJ, Bae KY, Kim SW, Shin MG, Cho KH and Kim JM: The impact of tumor necrosis factor-α and interleukin-1β levels and polymorphisms on long-term stroke outcomes. Eur Neurol. 79:38–44. 2018.PubMed/NCBI View Article : Google Scholar

24 

Chauhan G and Debette S: Genetic risk factors for Ischemic and Hemorrhagic stroke. Curr Cardiol Rep. 18(124)2016.PubMed/NCBI View Article : Google Scholar

25 

Ramazi S, Heydari-Zarnagh H, Goudarzian M, Khalaj-Kondori M and Bonyadi M: Thromboxane A synthase 1 gene expression and promotor haplotypes are associated with risk of large artery-atherosclerosis stroke in Iranian population. J Cell Biochem. 120:15222–15232. 2019.PubMed/NCBI View Article : Google Scholar

26 

Fan Y, Chen H, Li A, Shi Y, Zhang Y, Feng Q, Sun Y, Zheng H and He Y: A promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP gene is associated with decreased risk of ischemic stroke in two independent Chinese populations. PLoS One. 10(e0122393)2015.PubMed/NCBI View Article : Google Scholar

27 

Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P and Ganesh S: Inflammatory system gene polymorphism and the risk of stroke: A case-control study in an Indian population. Brain Res Bull. 75:158–165. 2008.PubMed/NCBI View Article : Google Scholar

28 

Tong Y, Wang Z, Geng Y, Liu J, Zhang R, Lin Q, Li X, Huang D, Gao S, Hu D, et al: The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: Analysis in two Chinese populations. Biochem Biophys Res Commun. 391:481–485. 2010.PubMed/NCBI View Article : Google Scholar

29 

Akhter MS, Biswas A, Abdullah SM, Hobani Y, Ranjan R, Behari M and Saxena R: Influence of interleukin-6 (IL-6) promoter gene polymorphisms (-174G>C, -572G>C, and -597G>A) on IL-6 plasma levels and their impact in the development of acute ischemic stroke in young Indians. Clin Appl Thromb Hemost. 25(1076029619854136)2019.PubMed/NCBI View Article : Google Scholar

30 

Yao YS, Chang WW and Jin YL: Association between TNF-α promoter -308G/A polymorphism and essential hypertension in the Asian population: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 18(1470320317741066)2017.PubMed/NCBI View Article : Google Scholar

31 

Tong Y, Geng Y, Xu J, Wang Z, Zhang Y, Lin L, Zhang R, Deng P, Li Y, Hou W, et al: The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies. Clin Chim Acta. 411:1291–1295. 2010.PubMed/NCBI View Article : Google Scholar

32 

Song D and Cheng D: Associations of TNFα-308G/A and TNFα-238G/A polymorphisms with ischemic stroke in East Asians and non-East Asians: A meta-analysis. Genet Test Mol Biomarkers. 21:10–16. 2017.PubMed/NCBI View Article : Google Scholar

33 

Faul F, Erdfelder E, Lang AG and Buchner A: G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39:175–191. 2007.PubMed/NCBI View Article : Google Scholar

34 

World Medical Association (WMA): WMA Declaration of Helsinki-ethical principles for medical research involving human subjects, 2018. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.

35 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al: 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 39:3021–3104. 2018.PubMed/NCBI View Article : Google Scholar

36 

Morgan JM and Capuzzi DM: Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines. Geriatrics. 58:33–38. 2003.PubMed/NCBI

37 

American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 40 (Suppl 1):S11–S24. 2017.

38 

Expert Dyslipidemia Panel. Grundy SM: An International atherosclerosis society position paper: Global recommendations for the management of dyslipidemia. J Clin Lipidol. 7:561–565. 2013.PubMed/NCBI View Article : Google Scholar

39 

Pongchaiyakul C, Nguyen TV, Wanothayaroj E, Karusan N and Klungboonkrong V: Prevalence of metabolic syndrome and its relationship to weight in the Thai population. J Med Assoc Thai. 90:459–467. 2007.PubMed/NCBI

40 

Ranganathan P, Pramesh CS and Aggarwal R: Common pitfalls in statistical analysis: Logistic regression. Perspect Clin Res. 8:148–151. 2017.PubMed/NCBI View Article : Google Scholar

41 

Erta M, Quintana A and Hidalgo J: Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 8:1254–1266. 2012.PubMed/NCBI View Article : Google Scholar

42 

Um JY and Kim HM: Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res. 122:99–102. 2004.PubMed/NCBI View Article : Google Scholar

43 

Kumari R and Kumar S, Ahmad MK, Singh R, Kant Kumar S, Pradhan A, Chandra S and Kumar S: Promoter variants of TNF-α rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian. Cytokine. 110:131–136. 2018.PubMed/NCBI View Article : Google Scholar

44 

Gu L, Wu G, Su L, Yan Y, Liang B, Tan J, Cai H, Jiang H, Wei Q, Shen T and Wei A: TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to the risk of ischemic stroke. Int J Neurosci. 126:219–226. 2016.PubMed/NCBI View Article : Google Scholar

45 

Linderson Y, Bresso F, Buentke E, Pettersson S and D'Amato M: Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms. Int J Colorectal Dis. 20:305–311. 2005.PubMed/NCBI View Article : Google Scholar

46 

Yu AC and Lau LT: Expression of interleukin-1 alpha, tumor necrosis factor alpha and interleukin-6 genes in astrocytes under ischemic injury. Neurochem Int. 36:369–377. 2000.PubMed/NCBI View Article : Google Scholar

47 

Yamaguchi A, Jitsuishi T, Hozumi T, Iwanami J, Kitajo K, Yamaguchi H, Mori Y, Mogi M and Sawai S: Temporal expression profiling of DAMPs-related genes revealed the biphasic post-ischemic inflammation in the experimental stroke model. Mol Brain. 13(57)2020.PubMed/NCBI View Article : Google Scholar

48 

Ye X, Kong D, Wang J, Ishrat T, Shi H, Ding X, Cui G and Hua F: MyD88 contributes to neuroinflammatory responses induced by cerebral ischemia/reperfusion in mice. Biochem Biophys Res Commun. 480:69–74. 2016.PubMed/NCBI View Article : Google Scholar

49 

Hao T, Yang Y, Li N, Mi Y, Zhang G, Song J, Liang Y, Xiao J, Zhou D, He D and Hou Y: Inflammatory mechanism of cerebral ischemia-reperfusion injury with treatment of stepharine in rats. Phytomedicine. 79(153353)2020.PubMed/NCBI View Article : Google Scholar

50 

Zhai Y, Zhu Y, Liu J, Xie K, Yu J, Yu L and Deng H: Dexmedetomidine post-conditioning alleviates cerebral ischemia-reperfusion injury in rats by inhibiting high mobility group protein B1 group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway. Med Sci Monit. 26(e918617)2020.PubMed/NCBI View Article : Google Scholar

51 

Yang JH, Chen WT, Lee MC, Fang WH, Hsu YJ, Chin-Lin Chen HC, Chang HL, Chen CF, Tu MY, et al: Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease. BMC Nephrol. 20(300)2019.PubMed/NCBI View Article : Google Scholar

52 

Chen J, Liu RY, Yang L, Zhao J, Zhao X, Lu D, Yi N, Han B, Chen XF, Zhang K, et al: A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk. J Cancer Res Clin Oncol. 139:231–242. 2013.PubMed/NCBI View Article : Google Scholar

53 

Kiss-Toth E, Harlock E, Lath D, Quertermous T and Wilkinson JM: A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation. PLoS One. 8(e76034)2013.PubMed/NCBI View Article : Google Scholar

54 

Yang X, Feng L, Li C and Li Y: Association of IL-6-174G>C and -572C>G polymorphisms with risk of young ischemic stroke patients. Gene. 539:258–262. 2014.PubMed/NCBI View Article : Google Scholar

55 

Jerrard-Dunne P, Sitzer M, Risley P, Steckel DA, Buehler A, von Kegler S and Markus HS: Carotid Atherosclerosis Progression Study. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: The carotid atherosclerosis progression study (CAPS). Stroke. 34:402–407. 2003.PubMed/NCBI View Article : Google Scholar

56 

Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, Lang W, Wagner O, Cheng S and Mannhalter C: Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med. 44:918–923. 2006.PubMed/NCBI View Article : Google Scholar

57 

Padovani JC, Pazin-Filho A, Simões MV, Marin-Neto JA, Zago MA and Franco RF: Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res. 100:263–269. 2000.PubMed/NCBI View Article : Google Scholar

58 

Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, et al: Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr. 86:768–774. 2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kamdee K, Panadsako N, Mueangson O, Nuinoon M, Janwan P, Poonsawat W, Pongpanitanont P, Kitkumthorn N, Thongsroy J, Chunglok W, Chunglok W, et al: Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population. Biomed Rep 15: 78, 2021.
APA
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W. ... Chunglok, W. (2021). Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population. Biomedical Reports, 15, 78. https://doi.org/10.3892/br.2021.1454
MLA
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W., Pongpanitanont, P., Kitkumthorn, N., Thongsroy, J., Chunglok, W."Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population". Biomedical Reports 15.3 (2021): 78.
Chicago
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W., Pongpanitanont, P., Kitkumthorn, N., Thongsroy, J., Chunglok, W."Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population". Biomedical Reports 15, no. 3 (2021): 78. https://doi.org/10.3892/br.2021.1454
Copy and paste a formatted citation
x
Spandidos Publications style
Kamdee K, Panadsako N, Mueangson O, Nuinoon M, Janwan P, Poonsawat W, Pongpanitanont P, Kitkumthorn N, Thongsroy J, Chunglok W, Chunglok W, et al: Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population. Biomed Rep 15: 78, 2021.
APA
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W. ... Chunglok, W. (2021). Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population. Biomedical Reports, 15, 78. https://doi.org/10.3892/br.2021.1454
MLA
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W., Pongpanitanont, P., Kitkumthorn, N., Thongsroy, J., Chunglok, W."Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population". Biomedical Reports 15.3 (2021): 78.
Chicago
Kamdee, K., Panadsako, N., Mueangson, O., Nuinoon, M., Janwan, P., Poonsawat, W., Pongpanitanont, P., Kitkumthorn, N., Thongsroy, J., Chunglok, W."Promoter polymorphism of <em>TNF‑α</em> (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population". Biomedical Reports 15, no. 3 (2021): 78. https://doi.org/10.3892/br.2021.1454
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team